Biotech Scan

Scan

Biotech Scan

Scan symbols 33
ABBVALNYAMGNBEAMBIIBBMRNBNTXCRSPDHRDNAEDITEXASGILDILMNINCYIONSIQVISRGLABULEGNLLYMDTMRNANTLANVOPTGXRAREREGNRXRXSRPTTMOVRTXXBI
Watchlists 1
@biotech-scan
raw scan snapshot — prices as of scan date, not live 49 rows · screens, not recommendations superseded by2026-04-26-biotech-scanported fromresearch/classic/scans/_archive/2026-03-13-biotech-scan.mdscan slugbiotech-scansource typescan-archive

Life sciences tools in capitulation: TMO RSI 24.4, DHR RSI 24.0, MDT RSI 22.3, A RSI 26.5 — deep oversold. NVO collapsing (-22.1% 30D, -53% from high). MRNA surging +75.7% 3M on mRNA renaissance. Gene editing mixed: CRSP -13.1% 7D crash, EDIT +31.0% 7D spike. Large-cap pharma (LLY, AMGN, GILD) holding but fading.

Quick Snapshot

Signal Reading
Overall 🟡 SPLIT — Life sciences tools (TMO, DHR, A, MDT) in capitulation with RSIs 22-26. Large-cap pharma (LLY, AMGN, GILD, VRTX) holding near SMAs. mRNA (MRNA +75.7% 3M) the standout winner. NVO in structural breakdown. Gene editing volatile.
Leaders MRNA (+75.7% 3M, RSI 55.5), PTGX (+16.2% 30D, RSI 62.0), EDIT (+31.0% 7D), NTLA (+43.0% 3M)
Laggards MDT (RSI 22.3, -9.6% 30D), TMO (RSI 24.4, -7.4% 30D), DHR (RSI 24.0, -12.5% 30D), NVO (RSI 33.1, -22.1% 30D), SRPT (-83% from high)

Price Table — Large-Cap Pharma

Stock Price RSI SMA20 vs SMA 7D% 30D% Signal
LLY $985.28 42.6 $1,015.39 -3.0% +0.1% -4.9% 🟡 Below SMA, -13% from high
ABBV $219.70 39.6 $228.89 -4.0% -1.6% -5.7% 🟡 Approaching oversold
GILD $144.99 49.0 $148.47 -2.3% +0.7% -6.6% 🟡 Neutral, strong-up trend
AMGN $366.21 47.7 $376.49 -2.7% +0.2% -1.9% 🟡 Neutral, strong-up
REGN $745.77 42.4 $776.68 -4.0% -1.1% -5.9% 🟡 Below SMA, fading
BIIB $186.62 48.6 $190.83 -2.2% +0.6% -4.5% 🟡 Neutral, +20% vs SMA200
VRTX $485.55 54.0 $478.62 +1.4% +5.2% +4.4% 🟢 Above SMA, strong-up

Price Table — Biotech & Gene Editing

Stock Price RSI SMA20 vs SMA 7D% 30D% Signal
MRNA $52.56 55.5 $51.46 +2.1% +3.6% +19.6% 🟢 mRNA renaissance, +66% vs SMA200
NVO $38.11 33.1 $41.52 -8.2% +0.3% -22.1% 🔴 GLP-1 leader collapsing, -53% from high
ALNY $312.14 36.3 $325.41 -4.1% -0.6% +1.2% 🟡 Death cross, -35% from high
CRSP $48.75 39.3 $55.37 -12.0% -13.1% -8.3% 🔴 Gene editing selloff, death cross
BEAM $25.74 42.6 $27.70 -7.1% -2.3% -4.4% 🟡 Base editing weak
EDIT $2.51 61.6 $2.07 +21.2% +31.0% +49.4% 🟢 Spike — speculative
NTLA $12.90 48.6 $13.24 -2.6% -5.4% +11.0% 🟡 +43% 3M, volatile
LEGN $19.42 53.5 $18.75 +3.5% +15.6% +7.5% 🟡 Bouncing, -57% from high
BNTX $88.80 33.3 $103.90 -14.5% -10.7% -16.0% 🔴 BioNTech selloff

Price Table — Life Sciences Tools

Stock Price RSI SMA20 vs SMA 7D% 30D% Signal
TMO $464.38 24.4 $506.46 -8.3% -6.0% -7.4% 🔴 Capitulation — -19.4% 3M
DHR $187.98 24.0 $205.11 -8.3% -3.9% -12.5% 🔴 Capitulation — -16.8% 3M
A $111.94 26.5 $120.84 -7.4% -3.2% -10.4% 🔴 Agilent capitulation
MDT $87.13 22.3 $94.73 -8.0% -3.3% -9.6% 🔴 Medtronic capitulation
ISRG $472.16 34.7 $494.58 -4.5% -1.0% -4.3% 🟡 Approaching oversold, -22% from high
IQV $165.12 36.0 $170.51 -3.2% -4.8% -2.2% 🟡 -25.7% 3M selloff
ILMN $118.15 36.9 $123.16 -4.1% -7.3% +3.2% 🟡 Genomics weak

Price Table — Specialty & Diagnostics

Stock Price RSI SMA20 vs SMA 7D% 30D% Signal
PTGX $95.23 62.0 $89.28 +6.7% +5.6% +16.2% 🟢 Strong-up, near 52wk high
EXAS $103.33 54.4 $103.37 0.0% -0.0% +0.1% 🟡 Flat at highs, +42% vs SMA200
INCY $92.05 31.6 $99.12 -7.1% -3.8% -8.6% 🟡 Approaching oversold
IONS $72.57 32.0 $79.63 -8.9% -1.2% -11.3% 🟡 Approaching oversold
BMRN $59.89 49.3 $61.06 -1.9% +0.5% -0.1% 🟡 Neutral
DNA $6.44 36.9 $7.93 -18.7% -3.7% -26.7% 🔴 Ginkgo collapse, -64% from high
RARE $21.52 40.7 $22.13 -2.8% +3.0% -8.4% 🟡 -46% from high
SRPT $17.05 42.6 $17.51 -2.6% +6.1% -2.0% 🔴 -83% from high, destroyed
RXRX $3.30 36.1 $3.54 -6.9% -5.8% -7.8% 🔴 AI-bio selloff, -52% from high

Price Table — ETFs

Stock Price RSI SMA20 vs SMA 7D% 30D% Signal
XBI $122.85 43.7 $125.77 -2.3% +1.7% -0.3% 🟡 Neutral, +17% vs SMA200
LABU $153.24 42.4 $166.16 -7.8% +4.8% -2.7% 🟡 3x biotech fading

Entry Zones

Stock Entry Zone Thesis
TMO $450-470 RSI 24.4, capitulation. Life sciences monopoly. If macro, not structural — deep value.
DHR $180-190 RSI 24.0, capitulation. Danaher quality at a steep discount.
MDT $85-88 RSI 22.3, deepest oversold in scan. Medtronic at multi-year support.
LLY $950-985 RSI 42.6, below SMA. GLP-1 franchise leader.
ISRG $460-475 RSI 34.7, surgical robotics monopoly approaching oversold.
NVO Research first -22.1% 30D, -53% from high. GLP-1 competition or structural issue?

Action Matrix

Action Stocks Why
✅ STRONG BUY TMO, DHR, MDT RSI 22-24, capitulation territory. Quality franchises at deep discounts.
📈 ACCUMULATE LLY, GILD, AMGN Below SMAs, pharma compounders. DCA opportunity.
🔒 HOLD VRTX, MRNA, PTGX Above SMAs, strong momentum. Let them run.
🔍 RESEARCH NVO -22.1% 30D crash needs thesis validation. GLP-1 competition?
🔍 WATCH ISRG, INCY, IONS Approaching oversold, watch for stabilization.
❌ DON'T BUY SRPT, DNA, RXRX Broken thesis, avoid.

What Changed

Bottom line: Life sciences tools (TMO, DHR, A, MDT) are in full capitulation with RSIs 22-26 — these are quality franchises at deep discounts if the weakness is cyclical, not structural. NVO's -22.1% 30D crash is the most notable large-cap move. MRNA's +75.7% 3M surge is the biotech story of the quarter.

The Gold

Key Discoveries:

  • Life sciences tools capitulation: TMO/DHR/MDT/A all RSI < 27 — potential generational entry if cyclical
  • MRNA +75.7% 3M renaissance — mRNA thesis reviving, +66% above SMA200
  • NVO -53% from high — GLP-1 leader under pressure, needs investigation
  • CRSP -13.1% in one week — gene editing selloff accelerating

Mistakes to Avoid:

  • Don't assume life sciences RSI 22-24 is "the bottom" — can go lower on earnings misses
  • Don't chase EDIT +31% 7D spike — speculative and volatile
  • Don't buy NVO without understanding competitive dynamics

Open Questions:

  • Is the life sciences tools selloff driven by China weakness, biotech funding drought, or destocking?
  • What's driving NVO's crash — competition, pricing, or clinical setback?
  • Is MRNA's surge sustainable or a short squeeze?
10 events
DateTypeEvent
Mar 12 ScanBiotech Scan Mar 11 ScanBiotech Scan Mar 10 ScanBiotech Scan Mar 20 ScanBiotech Scan Mar 26 ScanBiotech Scan Mar 24 ScanBiotech Scan Apr 26 ScanBiotech Scan Apr 28 ScanBiotech Scan Mar 31 ScanBiotech Scan May 29 ScanBiotech Scan

No direct external sources are attached to this read.